Advancing AI in Motor Neuron Disease Research
AI Group Wins Prize for ALS Drug Discovery Breakthrough
The Sheffield-led Decode ALS consortium received £100,000 to advance AI-driven research for Motor Neuron Disease.
Researchers at the University of Sheffield looking at a digital screen showing 3D protein structures and genomic data for AI-driven ALS research.
Photo: Avantgarde News
The Decode ALS consortium, led by the University of Sheffield, won a £100,000 Discovery Award from the Longitude Prize on ALS [1][2]. The team uses an end-to-end artificial intelligence pipeline to find new treatments for Motor Neuron Disease (MND) [1]. This award recognizes their work in analyzing whole-genome sequencing and molecular data to predict drug effectiveness [1][3].
The group's technology studies how candidate drugs interact with specific protein structures [1]. By identifying these new targets, scientists hope to speed up the creation of effective therapies [1][2]. The Longitude Prize on ALS aims to incentivize innovations that provide clinical benefits for people living with the condition [3].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
sheffield.ac.uk
https://sheffield.ac.uk/news/race-decode-als-sheffield-scientists-awarded-global-prize-breakthrough-ai-drug-discovery
- 2.↗
miragenews.com
https://www.miragenews.com/sheffield-scientists-win-global-prize-for-als-1669375/
- 3.↗
alandavidsonfoundation.org
https://alandavidsonfoundation.org/committed-funding/longitude-prize-on-als/
Related stories
View all
Topics
About the author
Avantgarde News Desk covers advancing ai in motor neuron disease research and editorial analysis for Avantgarde News.